“Sentinel Lymph Node Biopsy Does Not Adversely Affect Survival of Breast Cancer Patients with Metastases Compared to Axillary Dissection”

https://pubmed.ncbi.nlm.nih.gov/38114365

The study found that sentinel lymph node biopsy (SLNB) does not adversely affect the survival of cT3-4c breast cancer patients with 1-2 sentinel lymph node metastases, compared to axillary lymph node dissection.